BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,778,433 | -21.0% | 95,150 | -0.6% | 0.06% | -12.7% |
Q2 2023 | $6,048,936 | +141164.3% | 95,711 | +0.6% | 0.06% | +37.0% |
Q1 2023 | $4,282 | -46.5% | 95,180 | -47.9% | 0.05% | -48.3% |
Q4 2022 | $8,002 | -99.9% | 182,660 | -12.4% | 0.09% | -45.7% |
Q3 2022 | $13,748,000 | +33.3% | 208,631 | +2.2% | 0.16% | +41.4% |
Q2 2022 | $10,310,000 | -8.0% | 204,188 | +16.4% | 0.12% | +8.4% |
Q1 2022 | $11,208,000 | +77.8% | 175,436 | +198.2% | 0.11% | +84.5% |
Q4 2021 | $6,302,000 | -29.3% | 58,834 | -32.1% | 0.06% | +34.9% |
Q3 2021 | $8,908,000 | +140.0% | 86,672 | +105.4% | 0.04% | +19.4% |
Q2 2021 | $3,712,000 | -3.7% | 42,190 | +6.5% | 0.04% | -5.3% |
Q1 2021 | $3,853,000 | -14.8% | 39,633 | -1.7% | 0.04% | -24.0% |
Q4 2020 | $4,523,000 | +18.8% | 40,334 | -1.8% | 0.05% | -3.8% |
Q3 2020 | $3,808,000 | +330.3% | 41,083 | +262.7% | 0.05% | +246.7% |
Q2 2020 | $885,000 | +37.9% | 11,328 | +3.1% | 0.02% | +15.4% |
Q1 2020 | $642,000 | -33.7% | 10,988 | -9.1% | 0.01% | -13.3% |
Q4 2019 | $968,000 | – | 12,082 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |